EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species

Rodrigo Rollin-Pinheiro, Mariana Ingrid Dutra da Silva Xisto iD, Yuri de Castro-Almeida, Victor Pereira Rochetti, Luana Pereira Borba-Santos iD, Yasmin da Silva Fontes iD, Antonio Ferreira-Pereira, Sonia Rozental, Eliana Barreto-Bergter iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0280964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Rodrigo Rollin-Pinheiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Química Biológica de Microrganismos, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Feder…. Hauptthemen laut MEDLINE: Antifungal Agents, Ascomycota, Scedosporium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scedosporium and Lomentospora species are opportunistic filamentous fungi that cause localized and disseminated infections in immunocompetent and immunocompromised patients. These species are considered resistant fungi due to their low susceptibility to most current antifungal agents used in healthcare settings. The search for new compounds that could work as promising candidate antifungal drugs is an increasing field of interest. In this context, in the present study we screened the Pandemic Response Box ® library (Medicines for Malaria Venture [MMV], Switzerland) to identify compounds with antifungal activity against Scedosporium and Lomentospora species. An initial screening of the drugs from this collection at 5 μM was performed using a clinical Scedosporium aurantiacum isolate according to the EUCAST protocol. Compounds with activity against this fungus were also tested against four other species ( S . boydii ¸ S . dehoogii , S . apiospermum and L . prolificans ) at concentrations ranging from 0.078 to 10 μM. Seven compounds inhibited more than 80% of S . aurantiacum growth, three of them (alexidine, amorolfine and olorofim) were selected due to their differences in mechanism of action, especially when compared to drugs from the azole class. These compounds were more active against biofilm formation than against preformed biofilm in Scedosporium and Lomentospora species, except alexidine, which was able to decrease preformed biofilm about 50%. Analysis of the potential synergism of these compounds with voriconazole and caspofungin was performed by the checkerboard method for S . aurantiacum . The analysis by Bliss methodology revealed synergistic effects among selected drugs with caspofungin. When these drugs were combined with voriconazole, only alexidine and amorolfine showed a synergistic effect, whereas olorofim showed an antagonistic effect. Scanning electron microscopy revealed that alexidine induces morphology alterations in S . aurantiacum biofilm grown on a catheter surface. Reactive oxygen species production, mitochondrial activity and surface components were analyzed by fluorescent probes when S . aurantiacum was treated with selected drugs and revealed that some cell parameters are altered by these compounds. In conclusion, alexidine, amorolfine and olorofim were identified as promising compounds to be studied against scedosporiosis and lomentosporiosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsAscomycotaScedosporiumHumansCaspofunginVoriconazoleBiguanidesAcetamidesPiperazinesPyrimidinesPyrroles

Substanzen

Antifungal AgentsCaspofunginVoriconazolealexidineBiguanidesolorofimAcetamidesPiperazinesPyrimidinesPyrroles

Autor:innen und Institutionen

  • Laboratório de Química Biológica de Microrganismos, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Programa de Biologia Celular e Parasitologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Laboratório de Bioquímica Microbiana, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Mariana Ingrid Dutra da Silva Xisto, Luana Pereira Borba-Santos, Yasmin da Silva Fontes, Eliana Barreto-Bergter

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Rollin-Pinheiro, R., Xisto, M. I. D. D. S., de Castro-Almeida, Y., Rochetti, V. P., Borba-Santos, L. P., Fontes, Y. D. S., Ferreira-Pereira, A., Rozental, S., & Barreto-Bergter, E. (2023). Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species. PLOS ONE. https://doi.org/10.1371/journal.pone.0280964

Vancouver

Rollin-Pinheiro R, Xisto MIDDS, de Castro-Almeida Y, Rochetti VP, Borba-Santos LP, Fontes YDS, et al. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species. PLOS ONE. 2023. doi:10.1371/journal.pone.0280964

BibTeX
@article{RollinPinheiro2023,
  author = {Rollin-Pinheiro, Rodrigo and Xisto, Mariana Ingrid Dutra da Silva and de Castro-Almeida, Yuri and Rochetti, Victor Pereira and Borba-Santos, Luana Pereira and Fontes, Yasmin da Silva and Ferreira-Pereira, Antonio and Rozental, Sonia and Barreto-Bergter, Eliana},
  title = {Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0280964}
}
Kostenlos starten →